NL7308199A - - Google Patents

Info

Publication number
NL7308199A
NL7308199A NL7308199A NL7308199A NL7308199A NL 7308199 A NL7308199 A NL 7308199A NL 7308199 A NL7308199 A NL 7308199A NL 7308199 A NL7308199 A NL 7308199A NL 7308199 A NL7308199 A NL 7308199A
Authority
NL
Netherlands
Application number
NL7308199A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US262903A external-priority patent/US3867380A/en
Priority claimed from US00289499A external-priority patent/US3855213A/en
Application filed filed Critical
Publication of NL7308199A publication Critical patent/NL7308199A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
NL7308199A 1972-06-14 1973-06-13 NL7308199A (cg-RX-API-DMAC7.html)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US262903A US3867380A (en) 1971-02-18 1972-06-14 3-Heterocyclic thiomethylcephalosporins
US00289499A US3855213A (en) 1971-02-18 1972-09-15 3-heterocyclic thiomethyl-cephalosporins
US35956773A 1973-05-11 1973-05-11

Publications (1)

Publication Number Publication Date
NL7308199A true NL7308199A (cg-RX-API-DMAC7.html) 1973-12-18

Family

ID=27401552

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7308199A NL7308199A (cg-RX-API-DMAC7.html) 1972-06-14 1973-06-13

Country Status (10)

Country Link
JP (1) JPS4949984A (cg-RX-API-DMAC7.html)
AU (1) AU474443B2 (cg-RX-API-DMAC7.html)
CA (1) CA999574A (cg-RX-API-DMAC7.html)
CH (1) CH585228A5 (cg-RX-API-DMAC7.html)
DE (1) DE2330307C2 (cg-RX-API-DMAC7.html)
ES (1) ES415874A1 (cg-RX-API-DMAC7.html)
FR (1) FR2187305B1 (cg-RX-API-DMAC7.html)
GB (1) GB1416503A (cg-RX-API-DMAC7.html)
IE (1) IE37793B1 (cg-RX-API-DMAC7.html)
NL (1) NL7308199A (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH16419A (en) * 1973-01-31 1983-09-29 Bristol Myers Co 7-(d-alpha-amino-alpha-(3'-methyl-4'-hydroxyphenyl)-acetamido)-3-(1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid,pharmaceutically acceptable esters and salts thereof
CA1074784A (en) * 1974-09-06 1980-04-01 Sumitomo Chemical Company N-ACYLAMINO-.alpha.-ARYLACETAMIDO CEPHALOSPORINS
IL49183A0 (en) * 1975-03-27 1976-05-31 Pfizer Novel cephalosporin derivatives,their preparation and pharmaceutical compositions containing them
JPS5346995A (en) * 1976-10-12 1978-04-27 Sangyo Kagaku Kenkyu Kyokai Antibacterial agents
WO2010087425A1 (ja) 2009-01-30 2010-08-05 国立大学法人京都大学 前立腺癌の進行抑制剤および進行抑制方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds

Also Published As

Publication number Publication date
IE37793L (en) 1973-12-14
GB1416503A (en) 1975-12-03
IE37793B1 (en) 1977-10-12
ES415874A1 (es) 1976-02-01
AU474443B2 (en) 1976-07-22
CH585228A5 (cg-RX-API-DMAC7.html) 1977-02-28
DE2330307C2 (de) 1983-03-10
DE2330307A1 (de) 1974-01-03
AU5695273A (en) 1974-12-19
JPS4949984A (cg-RX-API-DMAC7.html) 1974-05-15
FR2187305B1 (cg-RX-API-DMAC7.html) 1976-12-03
FR2187305A1 (cg-RX-API-DMAC7.html) 1974-01-18
CA999574A (en) 1976-11-09

Similar Documents

Publication Publication Date Title
FR2187305B1 (cg-RX-API-DMAC7.html)
JPS5416532B2 (cg-RX-API-DMAC7.html)
JPS5434751B2 (cg-RX-API-DMAC7.html)
JPS5119705Y2 (cg-RX-API-DMAC7.html)
FR2199905A5 (cg-RX-API-DMAC7.html)
FR2209114B1 (cg-RX-API-DMAC7.html)
JPS4920625U (cg-RX-API-DMAC7.html)
JPS4916890A (cg-RX-API-DMAC7.html)
JPS4917048A (cg-RX-API-DMAC7.html)
JPS49102004U (cg-RX-API-DMAC7.html)
JPS4899677A (cg-RX-API-DMAC7.html)
JPS48111822U (cg-RX-API-DMAC7.html)
JPS4881043U (cg-RX-API-DMAC7.html)
CH569197A5 (cg-RX-API-DMAC7.html)
BG18223A1 (cg-RX-API-DMAC7.html)
CH587602A5 (cg-RX-API-DMAC7.html)
BG17866A1 (cg-RX-API-DMAC7.html)
CH576549B5 (cg-RX-API-DMAC7.html)
CH561393A5 (cg-RX-API-DMAC7.html)
CH568307A5 (cg-RX-API-DMAC7.html)
CH569955A5 (cg-RX-API-DMAC7.html)
CH568124A5 (cg-RX-API-DMAC7.html)
CH572344A5 (cg-RX-API-DMAC7.html)
CH563039A5 (cg-RX-API-DMAC7.html)
CH572449A5 (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
BV The patent application has lapsed